Dr Reddy's launches migraine management device in Europe
The launch marks the company's entry into digital therapeutics in Europe, the Hyderabad-based drug major said in a statement. Nerivio is approved by the US Food and Drug Administration (USFDA), and is CE-mark certified in Europe. Dr Reddy's launched Nerivio in India last year.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Food and Drug Administration (FDA) | Headache | India Health | Information Technology | Migraine | Pharmaceuticals